FDA Approves Breakthrough Pancreatic Cancer Drug Daraxonrasib

The US FDA has approved daraxonrasib, a new drug for advanced pancreatic cancer, marking a significant advancement in treating the deadly disease.

iWitness comments

No comments yet — be the first to weigh in.

North America

United States· Detroit

First report 1h ago•Last update 12m ago

The US FDA has approved daraxonrasib, a new drug for advanced pancreatic cancer, marking a significant advancement in treating the deadly disease.

No comments yet — be the first to weigh in.